Coping with genetic evolution of viruses
Genetic evolution enables human pathogenic viruses to adapt in ways that can impact their transmissibility, the severity of the disease, the capacity to evade from the immune system, the response to treatments, and the performance of diagnostic tests. Laboratories employing PCR-based assays for diagnostics must ensure that their routine tests can detect newly emerging viral variants.
Post market surveillance is a mandatory requirement for molecular diagnostics manufacturers. This requirement is reinforced by the recently implemented In Vitro Diagnostics Regulation (IVDR).
In this webinar, the importance of both proactive and reactive approaches to post market surveillance programs will be discussed and illustrated with real world case studies.
Key learning objectives
After attending this webinar, participants will be able to:
- Discuss the major mechanisms driving viral evolution
- Explain the consequences of viral evolution in the context of clinical patient care, public health, and the operations of clinical virology laboratories
- Describe the Post Market Surveillance process implemented at Siemens Healthineers designed to ensure the efficacy of multiple PCR assays in detecting emerging viral variants
- Recognize the significance of proactive and reactive approaches to Post Market Surveillance programs through the analysis of recent real-life case studies
Who should attend
- Clinical virologists
- Laboratory directors
- Laboratory managers
- Clinical researchers
- Infectious disease specialists
- Public health professionals
- Epidemiologists
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.